Persistent carcinoma in cervical cancer screening: Non-participation is the most significant cause

Acta Cytologica

Volumn 55, Issue 5, 2011, Pages 433-437

  Marquardt, Katrin ^a   Büttner, Heinz H ^b   Broschewitz, Ulf ^c   Barten, Malte ^d   Schneider, Volker ^e  

^a Pathology Laboratory   (Germany)

^b Department of Gynecology   (Germany)

^c Pathology Laboratories   (Germany)

^d UNIVERSITY OF ROSTOCK   (Germany)

^e Pathology Laboratory   (Germany)

Author keywords

Carcinoma of the cervix; Cervical cancer screening; Microinvasive carcinoma; Screening failures; Screening history

Indexed keywords

ADENOCARCINOMA; ARTICLE; CANCER DIAGNOSIS; CANCER REGISTRY; CANCER SCREENING; DISEASE SEVERITY; FOLLOW UP; GERMAN FEDERAL REPUBLIC; HISTOPATHOLOGY; HUMAN; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TREATMENT REFUSAL; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY;

EID: 80155146975     PISSN: 00015547     EISSN: 19382650     Source Type: Journal    
DOI: 10.1159/000331811     Document Type: Article

References (20)

1. Ronco G, New Technologies for Cervical Cancer Screening (NTCC) Working Group: Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol 2010; 11: 249-257.
2. Kane S, Ajit D, Gavas S: Antibody antip16 ink4a in cervical cytology. Acta Cytol 2010; 54: 1071-1073.
3. IARC Handbook of Cancer Prevention: Cervix Cancer Screening. Lyon, IARC Press, 2005, vol 10.
4. Arbyn M, Ronco G, Cuzick J, Wentzensen N, Castle PE: How to evaluate emerging technologies in cervical cancer screening ? Int J Cancer 2009; 125: 2489-2496.
5. Anttila A, Ronco G, Working Group on the Registration and Monitoring of Cervical Cancer Screening Programmes in the European Union, within the European Network for Information on Cancer: Description of the national situation of cervical cancer screening in the member states of the European Union. Eur J Cancer 2009; 45: 2685-2708.
6. Anttila A, von Karsa L, Aasmaa A, Fender M, Patrick J, Rebolj M, Nicula F, et al: Cervical cancer screening policies and coverage in Europe. Eur J Cancer 2009; 45: 2649-2658.
7. Cuzick J: Editorial: routine audit of large scale cervical cancer screening programs. J Natl Cancer Inst 2008; 100: 605-606.
8. Kerek-Bodden H, Altenhofen L, Brenner G, Franke A: Final report: participation in cervical cancer screening in the years 2002, 2003 and 2004. Berlin, Zentralinstitut der KV, 2009, pp 1-108. http://www.zi-berlin.de/cms/ fileadmin/images/content/PDFs-alle/Diskussionspapier-ZervixCa.pdf.
9. Gustafsson L, Ponten J, Bergström R, Adami HO: International incidence rates of invasive cervical cancer before cytological screening. Int J Cancer 1997; 71: 159-165.
10. Schenck U, von Karsa L: Cervical cancer screening in Germany. Eur J Cancer 2000; 36: 2221-2226.
11. Möbius G: Cytological early detection of cervical carcinoma: possibilities and limitations. Analysis of failures. J Cancer Res Clin Oncol 1993; 119: 513-521.
12. Siebert U, Sroczynski G, Hillemanns P, Engel J, Stabenow R, Stegmaier C, Voigt K, Gibis B, Hölzel D, Goldie SJ: The German cervical cancer screening model: development and validation of a decision-analytic model for cervical cancer screening in Germany. Eur J Public Health 2006; 16: 185-192.
13. Briet MC, Berger THD, van Ballegooijen M, Boon ME, Rebolj M: Effects of streamlining cervical cancer screening the Dutch way. Acta Cytol 2010; 54: 1095-1100.
14. Andrae B, Kemetli L, Sparén P, Silfverdal L, Strander B, Ryd W, Dillner J, Törnberg S: creening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden. J Natl Cancer Inst 2008; 100: 622-629.
15. Sung HY, Kearney KA, Miller M, Kinney W, Sawaya GF, Hiatt RA: Papanicolaou smear history and diagnosis of invasive cervical carcinoma among members of a large prepaid health plan. Cancer 2000; 88: 2283-2289.
16. Leyden W, Manos M, Geiger A, Weinmann S, Mouchawar J, Bischoff K, Yood MU, Gilbert J, Taplin SH: Cervical cancer in women with comprehensive health care access: attributable factors in the screening process. J Natl Cancer Inst 2005; 97: 675-683.
17. Yang B, Morell S, Zuo Y, Roder D, Tracey E, Jelfs P: A case-control study of the protective benefit of cervical screening against invasive cervical cancer in NSW women. Cancer Causes Control 2008; 19: 569-576.
18. Boulanger JC, Fauvet R, Urrutiaguer S, Drean Y, Sevestre H, Ganry O, Bergeron C, Gondry: Cytological history of cases of invasive cervical cancer diagnosed in France 2006. Gynecol Obstet Fertil 2007; 35: 764-771.
19. Bos AB, Rebolj M, Habbema JD, van Ballegooijen M: Non-attendance is still the main limitation for the effectiveness of screening for cervical cancer in the Netherlands. Int J Cancer 2006; 119: 2372-2375.
20. Spayne J, Ackerman I, Milosevic M, Seidenfeld A, Covens A, Paszat L: Invasive cervical cancer: a failure of screening. Eur J Public Health 2008; 18: 162-165.